HomeEIKN • NASDAQ
add
Eikon Therapeutics Inc
Previous close
$10.58
Day range
$10.02 - $10.95
Year range
$9.46 - $17.40
Market cap
545.72M USD
Avg Volume
408.80K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 107.48M | 58.58% |
Net income | -79.66M | -22.69% |
Net profit margin | — | — |
Earnings per share | -26.23 | — |
EBITDA | -102.09M | -59.51% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 335.98M | 52.64% |
Total assets | 594.73M | 21.07% |
Total liabilities | 312.30M | 22.49% |
Total equity | 282.44M | — |
Shares outstanding | 54.14M | — |
Price to book | -0.04 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -79.66M | -22.69% |
Cash from operations | -41.72M | -75.75% |
Cash from investing | 40.71M | 399.33% |
Cash from financing | 1.09M | 1,046.32% |
Net change in cash | 75.00K | 100.48% |
Free cash flow | — | — |
About
Founded
2019
Headquarters
Website
Employees
384
